Prolonging patient survival is the ultimate goal of cancer therapy. A large proportion of mice treated with saline, xylan, and Sxy died during the therapy stage, with a median survival time of only 14–15 d. In the off-therapy stage, the lifespan of the SCXN group was significantly elon...
We thank all the patients for their participation and the study coordinators, nurses, and physicians for their assistance. funding Grant support: AVON® China breast cancer research grant and the National Natural Science Foundation of China (30972934) disclosure The authors have declared no conflicts...
One patient each in the tucatinib arm and the placebo arm did not have EQ-VAS data available. HR-QoL: health-related quality of life; CI: confidence interval; HR: hazard ratio. In all five EQ-5D-5L domains, most patients in both treatment arms reported only slight or no problems, and...
The use of platinum-based anticancer drugs, such as cisplatin, oxaliplatin, and carboplatin, is a common frontline option in cancer management, but they have debilitating side effects and can lead to drug resistance. Combination therapy with other chemot